✦ LIBER ✦

MONOCLONAL ANTIBODIES IN LEUKAEMIA AND LYMPHOMA

Book ID: 122609540
Publisher: The Lancet
Year: 1982
Tongue: English
Weight: 326 KB
Volume: 319
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(82)92107-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AN IMMUNOHISTOCHEMICAL STUDY OF TAL-1 PR

AN IMMUNOHISTOCHEMICAL STUDY OF TAL-1 PROTEIN EXPRESSION IN LEUKAEMIAS AND LYMPHOMAS WITH A NOVEL MONOCLONAL ANTIBODY, 2TL 242

✍ CHETTY, RUNJAN; PULFORD, KAREN; JONES, MARGARET; MATHIEU-MAHUL, DANIELE; CLOSE, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB

Fifty formalin fixed, paraffin-embedded cases of T-acute lymphoblastic leukaemia (T-ALL) from 12 bone marrow trephines and 38 lymph nodes were stained with a new monoclonal antibody, 2TL 242, raised against recombinant TALl protein. The antibody recognizes TAL-1 polypeptides of molecular weight 39 a

High-level expression of MRK 16 and MRK

High-level expression of MRK 16 and MRK 20 murine monoclonal antibody-defined proteins (170,000-180,000 P-glycoprotein and 85,000 protein) in leukaemias and malignant lymphomas

✍ Sugawara, I; Kodo, H; Ohkochi, E; Hamada, H; Tsuruo, T; Mori, S 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 1015 KB

SC3 monoclonal antibody defines a novel

SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytes

✍ Maria Nikolova; Margarita Guenova; Hristo Taskov; Anne Marie-Cardine; Laurence B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 444 KB

Monoclonal antibody HML-1 reactivity wit

Monoclonal antibody HML-1 reactivity with adult T-cell leukaemia/lymphoma and other lymphomas

✍ S. KITAJIMA; M. TOKUNAGA; M. GOTO; E. SATO; A. UTSUNOMIYA; M. OHTSUKA; S. HANADA 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

Monoclonal antibody therapy for lymphoma

✍ Peter Campbell; Robert Marcus 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Monoclonal antibodies are an exciting advance in the treatment of lymphoma. They are safe and well-tolerated, and exhibit little cross-resistance with conventional chemotherapeutic agents. In indolent lymphomas, antibody therapy has shown useful response rates, both as first-line therapy and in rela

Monoclonal Antibodies in Lymphoma: The F

Monoclonal Antibodies in Lymphoma: The First Decade

✍ Brian K. Link; Jonathan W. Friedberg 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 93 KB